abstract |
The present invention relates to a family of N-phenyl-prenylamine derivatives of the following formula (I) and their use in the treatment of cognitive, neurodegenerative or neurological diseases or disorders such as Alzheimer's disease or Parkinson's disease . The invention also relates to pharmaceutical compositions comprising those compounds. Furthermore, the present invention is directed to the use of said compounds in the manufacture of a medicament for the treatment and / or prevention of cognitive, neurodegenerative or neurological diseases or disorders. |